Read the latest edition of the HIV Vaccine Trials Network's HVTNews. This issue of the HVTNews showcases the Hutchinson Center-based Network's contribution to the HIV vaccine field in more than a decade of operation—from increasing the scientific knowledge to setting precedents in community engagement.
In addition to the Network's achievements, the issue provides highlights of the plenary sessions from the HVTN Fall Conference in Seattle, and an article explaining the importance of innate immunity in vaccinology.
Also in this edition:
- The RV144 Immune Correlates Analysis: Implications for Vaccine Evaluations
- Auxiliary Research Projects 2011 Table
- VISP and the HVTN's Commitment to Poststudy HIV Testing
- Calendar of upcoming meetings and conferences
Access a PDF of the spring HVTN newsletter here.
The HVTNews highlights the progress of the Network-an international collaboration of scientists and educators who are searching for an effective and safe HIV vaccine.
Headquartered at the Hutchinson Center, the Network's HIV Vaccine Trial Units are located at leading research institutions in 27 cities on four continents and led by internationally renowned HIV vaccine and prevention investigators.